Global Proto Oncogene Market & Clinical Pipeline Insight 2024: 19 Drugs Commercially Available in the Market and 166 are in Clinical Pipeline in Various Developmental Phases
26 Feb 2018 11:17 GMT
… Key market players are Dexa Medica, Eisai Pharmaceuticals, Exelixis, Pfizer, Novartis, … Targets for Treatment
Market Analysis of Proto Oncogene Therapeutic Drugs
Dosage … Tafinlar)
10.8 Vandetanib (Caprelsa, Zactima & Zictifa)
10.9 Vemurafenib …
The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
02 Aug 2022 00:04 GMT
… clinical trials of anlotinib in the treatment of SCLC … of Air Force Military Medical University, Xianyang Central Hospital … clinical trial with sunitinib as second-line treatment in … oxygen consumption after treatment with vandetanib (ZACTIMA; ZD6474) and …